Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · IEX Real-Time Price · USD
4.150
-0.290 (-6.53%)
At close: Jun 21, 2024, 4:00 PM
4.130
-0.020 (-0.48%)
After-hours: Jun 21, 2024, 7:49 PM EDT

Lantern Pharma Market Cap

Lantern Pharma has a market cap or net worth of $44.65 million as of June 21, 2024. Its market cap has decreased by -29.24% in one year.

Market Cap
44.65M
Enterprise Value
6.48M
1-Year Change
-29.24%
Ranking
Category
Stock Price
$4.15

Market Cap Chart

Since June 11, 2020, Lantern Pharma's market cap has decreased from $90.20M to $44.65M, a decrease of -50.50%. That is a compound annual growth rate of -16.01%.

History

DateMarket Cap% Change
Jun 21, 202444.60M-6.69%
Jun 20, 202447.80M-5.35%
Jun 18, 202450.50M-4.36%
Jun 17, 202452.80M-8.65%
Jun 14, 202457.80M-1.20%
Jun 13, 202458.50M-3.78%
Jun 12, 202460.80M1.16%
Jun 11, 202460.10M3.44%
Jun 10, 202458.10M-3.17%
Jun 7, 202460.00M-4.00%
Jun 6, 202462.50M-4.87%
Jun 5, 202465.70M-3.95%
Jun 4, 202468.40M1.79%
Jun 3, 202467.20M2.91%
May 31, 202465.30M-3.69%
May 30, 202467.80M4.79%
May 29, 202464.70M-2.71%
May 28, 202466.50M-1.48%
May 24, 202467.50M0.75%
May 23, 202467.00M-3.60%
May 22, 202469.50M2.81%
May 21, 202467.60M7.99%
May 20, 202462.60M-3.54%
May 17, 202464.90M-1.82%
May 16, 202466.10M-2.94%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
NextCure 45.32M
Tempest Therapeutics 45.10M
Aerovate Therapeutics 44.96M
Envoy Medical 44.88M
Ocean Biomedical 44.70M
Daré Bioscience 43.92M
Cytosorbents 43.45M
Daxor 43.14M
Market Cap Rankings